Literature DB >> 8292489

Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C.

S Weiler1, W Carson, Y Lee, D B Teplow, Y Kishimoto, J S O'Brien, J A Barranger, J M Tomich.   

Abstract

The sphingolipid activator protein, saposin C (also termed SAP 2), was chemically synthesized, purified, and characterized. The fully protected 82-residue protein was synthesized by automated solid-phase methods, with multiple recoupling steps resulting in a high average coupling efficiency of 98.8%. The overall yield was estimated to be approx 40%. Deprotection and cleavage of the peptide from the resin was followed by folding in the absence of chaotropic agents at pH 8.5. The protein was purified by reversed-phase high pressure liquid chromatography (HPLC) and its purity determined by capillary electrophoresis and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The composition of the synthetic saposin C was determined by amino acid analysis. Its sequence was verified by Edman sequence analysis of overlapping peptide fragments generated by chymotryptic and Staphylococcus aureus V8 digestions. The sequence at the C-terminus was determined by digestion with carboxypeptidase P, followed by phenylthiohydantoin (PTH) derivitization and HPLC analysis of the released amino acid residues. Deglycosylated native saposin C appeared as a lower molecular-weight species than synthetic saposin C on SDS-PAGE. This has been explained by amino acid and C-terminal analysis showing native saposin C to be two amino acids shorter at the C terminus than a deduced sequence (from cDNA) previously published. Synthetic saposin C displayed 85% of full biological activity as determined by its ability to stimulate glucocerebrosidase activity in vitro: Synthetic and native saposin C increased glucocerebrosidase catalyzed hydrolysis of 4-methylumbelliferyl beta-D-glucoside by factors of 6.0 and 7.1, respectively. Furthermore, synthetic and native saposin C share similar K(act) values (0.5 and 1.5 microM respectively) indicating that they bind to glucocerebrosidase with similar affinities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292489     DOI: 10.1007/BF02782499

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder.

Authors:  H Christomanou; A Chabás; T Pámpols; A Guardiola
Journal:  Klin Wochenschr       Date:  1989-10-02

2.  A totally synthetic histidine-2 ferredoxin: thermal stability and redox properties.

Authors:  E T Smith; J M Tomich; T Iwamoto; J H Richards; Y Mao; B A Feinberg
Journal:  Biochemistry       Date:  1991-12-17       Impact factor: 3.162

3.  Saposin A: second cerebrosidase activator protein.

Authors:  S Morimoto; B M Martin; Y Yamamoto; K A Kretz; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  A procedure for the rapid purification in high yield of human glucocerebrosidase using immunoaffinity chromatography with monoclonal antibodies.

Authors:  J M Aerts; W E Donker-Koopman; G J Murray; J A Barranger; J M Tager; A W Schram
Journal:  Anal Biochem       Date:  1986-05-01       Impact factor: 3.365

5.  The carbohydrate moiety of the activator protein for glucosylceramide beta-glucosidase.

Authors:  A Sano; N S Radin
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

Review 6.  Automated synthesis of peptides.

Authors:  R B Merrifield
Journal:  Science       Date:  1965-10-08       Impact factor: 47.728

7.  Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation.

Authors:  F S Furbish; C J Steer; N L Krett; J A Barranger
Journal:  Biochim Biophys Acta       Date:  1981-04-03

8.  Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.

Authors:  V K Sarin; S B Kent; J P Tam; R B Merrifield
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

9.  Interaction of saposins, acidic lipids, and glucosylceramidase.

Authors:  S Morimoto; Y Kishimoto; J Tomich; S Weiler; T Ohashi; J A Barranger; K A Kretz; J S O'Brien
Journal:  J Biol Chem       Date:  1990-02-05       Impact factor: 5.157

10.  Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.

Authors:  A Basu; R H Glew; L B Daniels; L S Clark
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

View more
  1 in total

1.  Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes.

Authors:  Rika Kojima; Mark Zurbruegg; Tianyi Li; Wojciech Paslawski; Xiaoqun Zhang; Per Svenningsson
Journal:  J Mol Neurosci       Date:  2022-09-24       Impact factor: 2.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.